%0 Journal Article %A Ingrid Marois %A Carole Forfait %A Catherine Inizan %A Elise Klement-Frutos %A Anabelle Valiame %A Daina Aubert %A Ann-Claire Gourinat %A Sylvie Laumond %A Emilie Barsac %A Jean-Paul Grangeon %A Cécile Cazorla %A Audrey Merlet %A Arnaud Tarantola %A Myrielle Dupont-Rouzeyrol %A Elodie Descloux %T Development of a bedside score to predict dengue severity %D 2020 %R 10.1101/2020.11.25.20238972 %J medRxiv %P 2020.11.25.20238972 %X Background In 2017, New Caledonia experienced an outbreak of severe dengue causing high hospital burden (4,379 cases, 416 hospital admissions, 15 deaths). We decided to build a local operational model predictive of dengue severity, which was needed to ease the healthcare circuit.Methods We retrospectively analyzed clinical and biological parameters associated with severe dengue in the cohort of patients hospitalized at the Territorial Hospital between January and July 2017 with confirmed dengue, in order to elaborate a comprehensive patient’s score. Patients were compared in univariate and multivariate analyses. Predictive models for severity were built using a descending step-wise method.Results Out of 383 included patients, 130 (34%) developed severe dengue and 13 (3.4%) died. Major risk factors identified in univariate analysis were: age, comorbidities, presence of at least one alert sign, platelets count <30×109/L, prothrombin time <60%, AST and/or ALT >10N, and previous dengue infection. Severity was not influenced by the infecting dengue serotype nor by previous Zika infection. Two models to predict dengue severity were built according to sex. Best models for females and males had respectively a median Area Under the Curve = 0.80 and 0.88, a sensitivity = 84.5% and 84.5%, a specificity = 78.6% and 95.5%, a positive predictive value = 63.3% and 92.9%, a negative predictive value = 92.8% and 91.3%. Models were secondarily validated on 130 patients hospitalized for dengue in 2018.Conclusion We built robust and efficient models to calculate a bedside score able to predict dengue severity in our setting. We propose the spreadsheet for dengue severity score calculations to health practitioners facing dengue outbreaks of enhanced severity in order to improve patients’ medical management and hospitalization flow.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the government of New Caledonia. The funder provided financial support to the study but did not participate in the design of the study, data collection, analysis, and interpretation or writing of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was granted by the Consultative Ethics Committee of NC, and by the internal ethical review board of the Territorial Hospital. Dengue fever is a compulsory declarative disease in NC. Oral informed consent to participate was obtained from all participating patients or their relatives retrospectively when consulted by telephone.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analysed during this study are included in this published article.ADEAntibody-Dependent EnhancementALTAlanine AminotransferaseASTAspartate AminotransferaseAUCArea Under the CurveDENVdengue virusICUIntensive Care UnitIgGtype G ImmunoglobulinIQRInterquartile RangeIU/LInternational Units/LNCNew CaledoniaNS1Non-Structural protein 1OROdds RatioROC curveReceiving Operating Characteristic curveRT-qPCRReverse Transcription-quantitative Polymerase Chain ReactionWHOWorld Health OrganizationZIKVZika virus %U https://www.medrxiv.org/content/medrxiv/early/2020/11/30/2020.11.25.20238972.full.pdf